Skip to main content
AmigoFish

The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data

From Beyond Biotech - the podcast from Labiotech · · 38 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Today I am welcoming two guests: Quin Wills, CEO of Ochre Bio (https://www.ochre-bio.com), a biotech developing RNA therapies for chronic liver disease using AI models, and Stéphane Barges, CEO of Lexogen (https://www.lexogen.com), an RNA transcriptomics company and NGS service provider. It’s a deep dive into cutting edge transcriptomics, human-first data, and artificial intelligence.

00:55: The challenges of liver disease

04:44: How Lexogen supports NGS drug discovery

07:29: Major transcriptomics developments

10:05: Designing high quality AI data

15:47: How the Ochre-Lexogen partnership began

17:17: Why a specialist partner is essential for scale

18:21: Lexogen delivers on the massive sequencing project

21:50: Why high quality data is crucial

27:02: Lexogen's role in AI discovery

34:51: Future plans and directions

This episode was produced with the support of Lexogen (https://www.lexogen.com). Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! (https://www.labiotech.eu/advertise/?utm_campaign=lead_generation&utm_medium=podcast_description&utm_source=podcast)

Stay updated by subscribing to our newsletter (https://www.labiotech.eu/newsletter/?utm_campaign=newsletter_promotion&utm_medium=podcast_description&utm_source=podcast)

To dive deeper into the topic:

- Deep phenotyping brings accuracy to precision medicine (https://www.labiotech.eu/in-depth/precision-medicine-deep-phenotyping/)

- Spatial Transcriptomics: A window into disease (https://www.labiotech.eu/in-depth/spatial-transcriptomics/)

- Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions (https://www.labiotech.eu/trends-news/spatial-transcriptomics-readcoor-10x/)

Back to Beyond Biotech - the podcast from Labiotech · Report a problem